A 2025 position statement outlining cardiometabolic health and cardiovascular risk management across a woman's life course.
Answers are grounded in this paper and cite their sources.
Informs sex-specific cardiometabolic targets for clinicians; extends prior guidelines to a full life-course perspective.
Introduction Cardiometabolic health can be characterized by ideal levels of serum glucose and lipids and of blood pressure (BP) in association with low adiposity and cardiovascular risk (CVR). Usually, cardiometabolic health is the absence of metabolic dysfunction characteristic of some diseases, such as cardiovascular diseases (CVD), type 2 diabetes mellitus (T2DM), and metabolic syndrome […]
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2025) studied this question. Cardiometabolic health in women is characterized by ideal levels of serum glucose, lipids, and blood pressure in association with low adiposity and cardiovascular risk.
Synapse has enriched 10 related papers. Consider them for comparative context: